Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
PubMed laboratory research record [PMID: 2201652] PubMed record related to this compound for laboratory literature review
A post hoc analysis of the REMODEL trial, presented by David Cherney, MD, PhD, and colleagues at the International Society of Nephrology World Congress of Nephrology in Yokohama, Japan, assessed the kidney-protective effects of semaglutide 1.0 mg among adults with type 2 diabetes (n=71), stratified by SGLT2 inhibitor use
Ren, L., Qi, K., Zhang, L., Bai, Z., Ren, C., Xu, X., Zhang, Z., & Li, X
After adjusting for confounding factors, liraglutide use was independently linked to significant improvements in liver fibrosis indicators, suggesting a potential beneficial effect of liraglutide in mitigating liver fibrosis in type 2 diabetes
Allez dans Rglages Gnral Mise jour logicielle pour mettre jour iOS, ou utilisez Chrome
US$ 27.68
US$ 28.64
US$ 25.32
US$ 28.55
US$ 20.19
